Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Quickcomparison

Dose Range Angiotensin (1-7) 0.5-1 mcg/kg–5-10 mcg/kg mcg BPC-157 250–500 mcg Frequency Once daily Administration As directed by healthcare provider Subcutaneous injection Cycle Length Ongoing/indefinite 4-6 weeks Onset Speed Moderate (1-2 weeks) Evidence Leve

This comparison does not assign a generated winner or score.

  • Dose Range
  • Angiotensin (1-7)
  • 0.5-1 mcg/kg–5-10 mcg/kg mcg
  • BPC-157
  • 250–500 mcg
  • Frequency
  • Once daily
  • Administration
  • As directed by healthcare provider
  • Subcutaneous injection
  • Cycle Length
  • Ongoing/indefinite
  • 4-6 weeks
  • Onset Speed
  • Moderate (1-2 weeks)
  • Evidence Level
  • Moderate human trials (Phase 1-2)
  • Strong preclinical (extensive animal studies)
  • Efficacy
More references

Related material